Drawing for XNANODEX

USPTO serial 99761178

XNANODEX

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
SAUNDERS, ANDREA DAWN
Law office
TMO LAW OFFICE 137

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with XNANODEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL SANDLIN DENNISTON

1819 Fifth Avenue NorthBirmingham, AL 35203

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements, cosmetics, and functional foods; Chemicals for use in biotechnological product developmentACTIVE—
003Non-medicated skin care preparations; Hair care preparations; Cosmetic preparations for body care; Non-medicated toiletry preparations; Body wash; Shower and bath gel; Bath oils; Skin conditioners; Skin moisturizer; Shaving gelACTIVE—
005Chemical preparations for pharmaceutical or medical purposes, namely, for encapsulating and delivering active pharmaceutical ingredients, nutrients, vitamins, minerals, amino acids, peptides, and botanical extracts; Chemical preparations for pharmaceutical or medical purposes, namely, for transdermal, oral, sublingual, and topical delivery of molecules; Chemical preparations for pharmaceutical or medical purposes, namely, for improving the absorption and bioavailability of pharmaceuticals, nutraceuticals, and cosmetic active ingredients; Chemical preparations for pharmaceutical or medical purposes, namely, for molecular encapsulation and controlled release applications, enhanced cellular penetration of active compounds; Chemical preparations for pharmaceutical or medical purposes, namely, for use as excipients in the formulation of enhanced-delivery pharmaceutical, nutritional, and cosmetic products; Chemical preparations for pharmaceutical or medical purposes, namely, for enhanced bioavailability and cellular uptake of therapeutic compounds, nutritional supplements, and cosmetic active ingredients; Dietary supplements; Nutritional supplements; Nutraceuticals for use as a dietary supplement for therapeutic purposes, namely, preparations for supporting cardiovascular health, metabolic function, cognitive health, immune function, skin health, and healthy aging, all featuring enhanced delivery via natural lipid nanoparticles; Medicated skin care preparations; Nutritional supplements for promoting cellular health and metabolic function, in the form of liquids, powders, capsules, and tablets, featuring advanced nano-emulsion delivery technology; Pharmaceutical preparations for the treatment of metabolic disorders, featuring enhanced bioavailability through natural lipid nanoparticle delivery systems; Pharmaceutical preparations for transdermal delivery of active pharmaceutical ingredients utilizing natural lipid-based nano-emulsion technologyACTIVE—
030Coffee drinks; Coffee; Coffee and coffee substitutes; TeaACTIVE—
032Soft drinks; Energy drinks; Beer; Seltzer waterACTIVE—
033Alcoholic seltzers; Hard seltzer; Distilled spirits; Spirits and liqueursACTIVE—
042Research and development services in the field of pharmaceutical preparations; Research and development services in the field of cosmetics; Research and development in the field of polypharmacy and parenteral multi-nutrient delivery; Research and development and consultation related thereto in the field of nutritional supplements; Research and development and consultation related thereto in the field of life sciences; Research and development and consultation related thereto in the field of biomaterials; Research and development and consultation related thereto in the field of wellness solutions and platforms; Scientific research; Scientific research and development; Product development; Product development consultation; Product research and development; Design and testing for new product development; Technological planning and consulting services in the field of molecular delivery systems; Research and development in the field of biotechnology; Biotechnology research; Biotechnology research in the field of uptake mechanisms and enhanced molecular transport; Quality control of goods and services; Scientific laboratory services; Scientific and technological services, namely, research, analysis, and testing in the field of bioavailability enhancement using natural lipid nanoparticle platformsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2026DOCKASSIGNED TO EXAMINER—
Jul 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 13, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance